Abstracts Archive - Page 513 of 1683 - ATC Abstracts

2020 American Transplant Congress
HELLP Me! My Liver Ruptured and Nobody Can Give Me Platelets: A Case Study of Liver Transplantation for Liver Rupture from HELLP Syndrome
R. Cooke, M. Williams, M. A. Adams
UCHealth University of Colorado Hospital, Aurora, CO
*Purpose: Liver rupture and infarction are rare but serious complications of hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. We report successful utilization…
2020 American Transplant Congress
Multifactorial Effect of Hepatocyte Growth Factor (HGF) on the Microscopic Regeneration of Liver Allograft in Recipients Who Underwent Transplantation from Living Donors
B. H. Ozdemir¹, G. Ozgun¹, A. Yucel Polat¹, M. Haberal²
¹Pathology, Baskent University, Ankara, Turkey, ²Department of General Surgery, Division of Transplantation, Baskent University, Ankara, Turkey
*Purpose: Although partial liver allografts from living donors have near-complete regeneration of their liver volumes within weeks after transplantation, the microscopic range of regeneration is…
2020 American Transplant Congress
The Living Donor Collective Pilot Evaluations of Living Liver Donor Candidates at 6 Programs
B. Kasiske, M. Conboy, Y. Ahn, A. Israni, J. Snyder
SRTR, Minneapolis, MN
*Purpose: Much remains to learn regarding the long-term effects of living organ donation on donors. Rare events are important, and long-term follow-up with appropriate contemporaneous…
2020 American Transplant Congress
The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is it Time to Split the Difference?
D. Yoeli¹, M. Adams¹, R. Choudhury¹, T. Nydam¹, J. Pomposelli¹, J. Goss², M. Wachs¹
¹Transplant Surgery, University of Colorado, Aurora, CO, ²Transplant Surgery, Baylor College of Medicine, Houston, TX
*Purpose: The opioid epidemic afflicting our nation has led to a surge in the number of adult deceased donors from drug overdose. We hypothesized that…
2020 American Transplant Congress
Atrial Fibrillation Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort
M. German¹, A. Hristov¹, A. Lee¹, F. Osman¹, A. Kwong², D. Devuni³, C. Wang⁴, J. Boike⁵, J. Jo⁵, L. VanWagner⁵, M. Serper⁶, R. Sharma⁷, E. Verna⁷, J. Shor³, A. Koteish⁸, G. Sehmbey⁹, A. Seetharam⁹, N. John², Y. Patel¹⁰, M. Kappus¹⁰, T. Couri¹¹, S. Paul¹¹, R. Salgia¹², Q. Nhu¹³, C. Frenette¹³, J. Lai⁴, A. Goel², E. Spengler¹
¹U of Wisconsin, Madison, WI, ²Stanford, Palo Alto, CA, ³U of Massachusetts, Worcester, MA, ⁴U of California, San Francisco, CA, ⁵Northwestern, Chicago, IL, ⁶U of Pennsylvania, Philadelphia, PA, ⁷Columbia, New York, NY, ⁸Florida Hospital, Orlando, FL, ⁹U of Arizona, Phoenix, AZ, ¹⁰Duke, Durham, NC, ¹¹U of Chicago, Chicago, IL, ¹²Henry Ford Hospital, Detroit, MI, ¹³Scripps, San Diego, CA
*Purpose: More liver transplants (LT) are being performed in patients >65 years (y) - a population with higher rates of cardiovascular (CV) disease. It is…
2020 American Transplant Congress
Bariatric Surgery to Improve Candidacy for Liver Transplantation: A Systematic Review and Meta-Analysis
J. Purvis¹, R. Stahl¹, J. Grams¹, M. Gray¹, D. Eckhoff¹, R. Cannon¹, C. Lewis¹, N. Terrault², J. Locke¹, B. Orandi¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Southern California, Los Angeles, CA
*Purpose: As non-alcoholic steatohepatitis grows as an indication for liver transplant, the challenge managing obese pre-liver transplant patients will become more pronounced, especially because most…
2020 American Transplant Congress
Percutaneous Choledochoscopy and Laser Biliary Stricturoplasty: A Case Series of Novel Management of Refractory Post-Liver Transplant Biliary Complications
W. E. Jackson¹, P. S. Trivedi², J. J. Pomposelli³, T. J. Pshak³
¹Division of Gastroenterology and Hepatology, University of Colorado, Aurora, CO, ²Division of Vascular and Interventional Radiology, University of Colorado, Aurora, CO, ³Division of Transplant Surgery, University of Colorado, Aurora, CO
*Purpose: Anastomotic biliary strictures are a well-recognized complication after living and deceased donor liver transplant (LDLT and DDLT). Management focuses on utilizing endoscopic retrograde cholangiography…
2020 American Transplant Congress
Initial Experience of the First 13 Cases of Purely Laparoscopic Living Donor Right Hepatectomy
H. Choi¹, C. Seo¹, J. Ahn¹, G. Na², Y. You¹
¹Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of, ²Department of Surgery, Bucheon St. Mary’s Hospital, The Catholic University of Korea, Bucheon, Korea, Republic of
*Purpose: Laparoscopic major hepatectomy is gradually increasing with two consensus meetings. However, purely laparoscopic donor right hepatectomy (PLDRH) is still being performed carefully, because donor…
2020 American Transplant Congress
Sparing the Nephron in Liver Transplant Recipients with Antithymocyte Bridging: A Four Year Experience
N. Wilson, H. Kuzaro, N. Parrish, S. A. Shah, N. Anwar, R. R. Alloway, S. Tremblay, T. E. Kaiser
U Cincinnati, Cincinnati, OH
*Purpose: Renal function decline after liver transplant (LT) remains a significant issue. Using antithymocyte globulin (rATG) to delay tacrolimus (TAC) initiation may impact renal deterioration;…
2020 American Transplant Congress
Clinical Study of Standard versus Reduced Dose Tacrolimus Combined with Generic Mycophenolate Mofetil in De Novo Kidney Transplantation
J. Bang, C. Oh
Department of Surgery, Ajou University Medical School, Suwon, Korea, Republic of
*Purpose: The lowering of calcineurin inhibitor exposure is possibly considered as the proper strategy to prevent calcineurin inhibitor induced nephrotoxicity in kidney transplant. This clinical…